Genentech aims to make a positive impact on society beyond their core mission of developing medicines. For over 45 years, the company has been a top philanthropist in the Bay Area, focusing on cultivating a diverse future in STEM, addressing health equity, and engaging in community giving. Their efforts are directed towards supporting underrepresented backgrounds in their educational and career journeys in science and medicine, tackling systemic health inequities, and contributing to the wellbeing of their local communities through partnerships and employee volunteerism.
The grant program focuses on supporting independent medical education for healthcare professionals, provided by various educational providers like community hospitals, academic centers, and medical education companies. Genentech/Roche is interested in funding projects in specific disease states, including Age-Related Macular Degeneration, Asthma, Chronic Urticaria, COVID-19, Diabetic Macular Edema, Diabetic Retinopathy, Food Allergy, Hemophilia, Hematologic Malignancy (with a focus on Lymphoma, Diffuse Large B-Cell, Follicular, Non-Hodgkins), Influenza, Lung Cancer (Non-Small Cell ALK Positive), Lupus, Macular Edema, Myasthenia Gravis, Neuromyelitis Optica, Paroxysmal Nocturnal Hemoglobinuria, Retinal Vein Occlusion, and Spinal Muscular Atrophy.